# FDA Inspection 1121623 - Reactimex S.A. de C.V. - March 05, 2020

Source: https://www.keypedia.com/records/fda_inspections/reactimex-sa-de-cv/71f4edc6-6243-41ce-b90c-2a9faa4f6b7d
Source feed: FDA_Inspections

> FDA Inspection 1121623 for Reactimex S.A. de C.V. on March 05, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121623
- Company Name: Reactimex S.A. de C.V.
- Inspection Date: 2020-03-05
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275318 - 2025-05-29](https://www.keypedia.com/records/fda_inspections/reactimex-sa-de-cv/1ba74678-fe8f-41c0-bd2b-d839454565f4)
- [FDA Inspection 1275318 - 2025-05-29](https://www.keypedia.com/records/fda_inspections/reactimex-sa-de-cv/74afc3cb-8618-4264-97ef-4479f586d65c)

Company: https://www.keypedia.com/companies/reactimex-sa-de-cv/64312e9e-1f0b-42f7-bc6e-ac95307cf1c9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c